CAXTON ASSOCIATES LLP: ECG position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAXTON ASSOCIATES LLP on ECG, newest first. How the timeline and the estimate are built.
CAXTON ASSOCIATES LLP held 2,480 ECG shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 2,480 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $291,450.
13F-HR 0002051323-26-000017 filed by CAXTON ASSOCIATES LLP
Accepted , ingested